A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer

British Journal of Cancer

Volumn 77, Issue 11, 1998, Pages 1966-1970

  Hickish, T F ^a   Smith, I E ^a   Nicolson, M C ^a   Ashley, S ^a   Priest, K ^a   Spencer, L ^a   Norman, A ^a   Middleton, G ^a   O'Brien, M E R ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; MVP; Small cell lung cancer

Indexed keywords

CISPLATIN; MITOMYCIN C; VINBLASTINE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONSTIPATION; COUGHING; DIARRHEA; DYSPNEA; EMOTION; FEMALE; HAIR LOSS; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MALE; MUCOSA INFLAMMATION; NAUSEA; NEPHROTOXICITY; NEUROPATHY; NEUTROPENIA; PAIN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; THROMBOCYTOPENIA; VOMITING;

EID: 0031779929     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.326     Document Type: Article

References (29)

1. Bishop JF, Raghavan D, Stuart Harris R, Morstyn G, Aroney R, Kefford R, Yuen K, Lee J, Gianoutsos P, Olver IN, Zalcberg J, Ball D, Bull C and Fox R (1987) Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer. J Clin Oncol 5: 1574-1578
2. Bleehen NM, Girling DJ, Hopwood P, Lallemand B, Machin RJ and Bailey AJ for the Medical Research Council Lung Cancer Working Party (1996) Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patient with small-cell lung cancer (SCLC) and poor prognosis. Br J Cancer 73: 406-413
3. Broder LE, Sridhar KS, Selawry OS, Charyulu KN, Rao RK, Saldana MJ, Donnelly EJ and Raub WA (1994) A randomised clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine and etoposide (VAPE) with maintenance CCNU and methotrexate (CCM) versus CCM maintenance alone in complete responders following VAPE induction and late intensification. Am J Clin Oncol 17: 527-537
4. Brugger W, Frommhold H, Pressler K, Mertelsmann R and Kanz L (1995) Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer. Semin Oncol 22: 3-8
5. Ellis PA, Smith IE, Hardy JR, Nicolson MC, Talbot DC, Ashley SE and Priest K (1995a). Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer. Br J Cancer 71: 366-370
6. Ellis PA, Talbot DC, Priest K, Jones AL and Smith IE (1995b) Dose intensification of carboplatin and etoposide as first-line combination chemotherapy in small cell lung cancer (letter). Eur J Cancer 31a: 1888-1889
7. Evans WK, Eisenhauer E, Hughes P, Maroun JA, Ayoub J, Shepherd FA and Feld R (1988) VP-16 and carboplatin in previously untreated patients with extensive small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group. Br J Cancer 58: 464-468
8. Fetscher S, Brugger W, Englehardt R, Kanz L, Hasse J, Frommhold H, Wenger M, Lange W and Mertelsmann R (1997) Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer. Ann Oncol 8: 49-56
9. Fukuoka M, Furuse K, Saijo N, Nishiwaki Y, Ikegami H, Tamura T, Shimoyama M and Suemasu K (1991) Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. J Natl Cancer Inst 83: 855-861
10. Girling D, Thatcher N, Clark PI, Hopwood P, Twiddy S, Stephens RJ, Bailey AJ, Machin D, Bleehen NM, Bolger JJ, Connolly CK, Haselton PS, Macbeth FR, Moghissi K, Saunders MI, White RJ, Alcock S, Burt H, Crossley E, Decker E, English J, Foster G, Hannigan K, Heron D, Hutchinson J, for the Medical Research Council Lung Cancer Working Party (1996) Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Lancet 348: 563-566
11. Harper PG and Souhami RL (1985) Intensive chemotherapy with autologous bone marrow transplantation in small cell carcinoma of the lung. Recent Results Cancer Res 97: 146-156
12. Humblet Y, Symann M, Bosly A, Delaunois L, Francis C, Machiels J, Beauduin M, Doyen C, Weynants P, Longueville J and Prignot J (1987) Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study. J Clin Oncol 5: 1864-1873
13. Ihde DC, Deisseroth AB, Lichter AS, Bunn PA, Carney DN, Cohen MH, Veach SR, Makuch RW, Johnston-Early A, Abrams RA, Messerschmidt GL, Matthews MJ and Minna JD (1986) Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer. J Clin Oncol 4: 1443-1454
14. Inada T (1988) In vitro chemosensitivity tests of human lung small cell carcinomas - with reference to combination cancer chemotherapy. Nippon Geka Gakkai Zasshi 89: 256-264
15. Jones AL, Holborn J, Ashley S and Smith IE (1991). Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide. Eur J Cancer 27: 866-870
16. Jones AL, Holborn J, Ashley S and Smith IE (1993) CVM versus ACE in the treatment of small cell lung cancer. Oncology 50: 10-15
17. Joss RA, Alberto P, Hurny C, Bacchi M, Leyvraz S, Thurlimann B, Cerny T, Martinelli G, Stahel R and Ludwig C (1995) Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol 6: 41-48
18. Kaplan EL and Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-181
19. Klasa RJ, Murray N and Coldman AJ (1991) Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung. J Clin Oncol 9: 499-508
20. Leyvraz S, Ketterer N, Perey L, Bauer J, Vuichard P, Grob JP, Schneider P, von Fliedner V, Lejeune F and Bachmann F (1995) Intensification of chemotherapy for the treatment of solid tumours: feasibility of a 3-fold increase in dose intensity with peripheral blood progenitor cells and granulocyte colony-stimulating factor. Br J Cancer 72: 178-182
21. McHale MS and Einhorn LH (1986) Phase II study of mitomycin in small cell lung carcinoma. Cancer Treat Rep 70: 675
22. Miller AB, Hoogstraten B, Staquet M and Winkler, A (1981) Reporting results of cancer treatment. Cancer 47: 207-214
23. Murray N, Shah A, Wilson K, Goldie J, Voss N, Fryer C, Klimo P, Coy P, Hadzic E, Gudauskas G and Fowler R (1985) Cyclic alternating chemotherapy for small cell carcinoma of the lung. Cancer Treat Rep 69: 1241-1242
24. Roth BJ, Johnson DH, Einhorn LH, Schacter LP, Cherng KC, Cohen HJ, Crawford J, Randolph JA, Goodlow JL, Broun GO, Omura GA and Greco FA (1992) Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 10: 282-291
25. Smith IE (1992) Carboplatin in small cell lung cancer. Semin Oncol 19: 24-27
26. Smith IE, Evans BD, Harland SJ, Robinson BA, Yarnold JR, Glees JG and Ford HT (1985) High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinoma. Cancer Chemother Pharmacol 14: 120-124
27. Smith IE, Evans BD, Gore ME, Repetto L, Yarnold JR and Ford HT (1987) Carboplatin (Paraplatin; JM8) and Etoposide (VP-16) as first-line combination therapy for small-cell lung cancer. J Clin Oncol 5: 185-189
28. Smith IE, Perren TJ, Ashley SA, Woodiwiss J, Forgeson GV, Yarnold JR and Ford HT (1990) Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer. J Clin Oncol 8: 899-905
29. Woll PJ, Hodgetts J, Lomax L, Bildet F, Cour Chabernaud V and Thatcher N (1995) Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer. J Clin Oncol 13: 652-659